Barclays Has Lowered Expectations for Intellia Therapeutics (NASDAQ:NTLA) Stock Price
Intellia Therapeutics (NASDAQ:NTLA – Free Report) had its target price reduced by Barclays from $55.00 to $26.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight ...
Verisk Analytics (NASDAQ:VRSK) Price Target Raised to $297.00 at BMO Capital Markets
Verisk Analytics (NASDAQ:VRSK – Free Report) had its price target hoisted by BMO Capital Markets from $280.00 to $297.00 in a ...
Victory Capital stock target raised to $82 at BMO Capital
BMO Capital Markets increased the price target for Victory Capital Holdings, Inc. (NASDAQ:VCTR) to $82.00 from $73.00, while maintaining an Outperform rating on the stock. The adjustment follows a ...
Cubesmart (CUBE) Receives a Hold from Barclays
In a report released today, Brendan Lynch from Barclays maintained a Hold rating on Cubesmart (CUBE – Research Report), with a price target of ...
Barclays Keeps Their Buy Rating on Extra Space Storage (EXR)
In a report released today, Brendan Lynch from Barclays maintained a Buy rating on Extra Space Storage (EXR – Research Report), with a price ...
Bloomberg L.P.6d
BMO Beats Estimates as Capital Markets Post Strong Performance
Bank of Montreal beat estimates as it benefited from strong performance in its capital-markets business and set aside less money than expected to cover possible loan losses. The Canadian bank ...
Yahoo Finance6d
BMO, Scotiabank Beat Estimates on Capital-Markets Results
(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.